NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,179,539 | +13.2% | 11,580 | +12.1% | 0.47% | +22.1% |
| Q2 2023 | $1,042,098 | +8.8% | 10,327 | -0.8% | 0.38% | +2.7% |
| Q1 2023 | $957,904 | -8.2% | 10,412 | -9.5% | 0.38% | -10.7% |
| Q4 2022 | $1,044,006 | -99.9% | 11,508 | +0.0% | 0.42% | -4.8% |
| Q3 2022 | $874,419,000 | -10.3% | 11,504 | -0.3% | 0.44% | -3.9% |
| Q2 2022 | $974,885,000 | -11.0% | 11,533 | -7.6% | 0.46% | +9.5% |
| Q1 2022 | $1,095,208,000 | +1.3% | 12,481 | +1.0% | 0.42% | +14.8% |
| Q4 2021 | $1,080,780,000 | +4.5% | 12,356 | -2.3% | 0.36% | -1.4% |
| Q3 2021 | $1,034,435,000 | -10.6% | 12,649 | -0.3% | 0.37% | -5.6% |
| Q2 2021 | $1,157,470,000 | +3.0% | 12,686 | -3.5% | 0.39% | -3.0% |
| Q1 2021 | $1,123,463,000 | -10.3% | 13,143 | -0.9% | 0.40% | -11.6% |
| Q4 2020 | $1,252,992,000 | +6.2% | 13,269 | -2.2% | 0.46% | -6.0% |
| Q3 2020 | $1,180,221,000 | +0.6% | 13,572 | -4.6% | 0.49% | -20.3% |
| Q1 2020 | $1,172,851,000 | -14.1% | 14,225 | -1.4% | 0.61% | +12.8% |
| Q4 2019 | $1,365,903,000 | +12.1% | 14,425 | +2.9% | 0.54% | +1.3% |
| Q3 2019 | $1,218,251,000 | -5.9% | 14,019 | -1.2% | 0.53% | -7.9% |
| Q2 2019 | $1,295,050,000 | -4.4% | 14,183 | +0.6% | 0.58% | -5.8% |
| Q1 2019 | $1,355,286,000 | +7.0% | 14,097 | -4.5% | 0.62% | -8.5% |
| Q4 2018 | $1,266,813,000 | -2.1% | 14,763 | -1.7% | 0.67% | +13.1% |
| Q3 2018 | $1,293,520,000 | +12.9% | 15,013 | -1.0% | 0.60% | +4.6% |
| Q2 2018 | $1,145,337,000 | -21.0% | 15,162 | -15.5% | 0.57% | -18.7% |
| Q1 2018 | $1,450,611,000 | -6.2% | 17,942 | -2.6% | 0.70% | -5.5% |
| Q4 2017 | $1,547,047,000 | -4.0% | 18,426 | -1.8% | 0.74% | -7.8% |
| Q3 2017 | $1,611,233,000 | +3.6% | 18,768 | +0.8% | 0.80% | +1.0% |
| Q2 2017 | $1,554,795,000 | +13.5% | 18,627 | +1.0% | 0.80% | +12.3% |
| Q1 2017 | $1,369,613,000 | -1.2% | 18,441 | -3.1% | 0.71% | -4.4% |
| Q4 2016 | $1,386,874,000 | -14.0% | 19,040 | -6.8% | 0.74% | -16.3% |
| Q3 2016 | $1,612,363,000 | -2.1% | 20,420 | +2.3% | 0.89% | -3.2% |
| Q2 2016 | $1,646,405,000 | +13.1% | 19,954 | -0.7% | 0.92% | +13.0% |
| Q1 2016 | $1,456,334,000 | -36.7% | 20,104 | -24.8% | 0.81% | -36.7% |
| Q4 2015 | $2,300,968,000 | -17.9% | 26,743 | -12.3% | 1.28% | -21.1% |
| Q3 2015 | $2,804,203,000 | -1.9% | 30,507 | +5.0% | 1.62% | +7.6% |
| Q2 2015 | $2,857,564,000 | +1.4% | 29,058 | +1.7% | 1.51% | +8.6% |
| Q1 2015 | $2,817,780,000 | -41.7% | 28,575 | -44.8% | 1.39% | -41.8% |
| Q4 2014 | $4,832,563,000 | +113.9% | 51,773 | +115.7% | 2.38% | +110.4% |
| Q3 2014 | $2,258,932,000 | +10.4% | 23,998 | +6.2% | 1.13% | +15.0% |
| Q2 2014 | $2,045,616,000 | +33.0% | 22,596 | +24.9% | 0.98% | -1.2% |
| Q1 2014 | $1,537,927,000 | +15.4% | 18,089 | +9.1% | 1.00% | +11.6% |
| Q4 2013 | $1,332,861,000 | +13.5% | 16,582 | +8.3% | 0.89% | +2.5% |
| Q3 2013 | $1,174,123,000 | +19.8% | 15,306 | +10.5% | 0.87% | +14.8% |
| Q2 2013 | $979,828,000 | – | 13,857 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |